E Holz
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Immunotherapy and Immune Responses 2
- Toxin Mechanisms and Immunotoxins 1
- Oncology 4
- Colorectal Cancer Treatments and Studies 2
- Peptidase Inhibition and Analysis 1
- Co-authors
- Rudolf Gruber (3 shared papers)G. Riethmüller (4 shared papers)R. Raab (2 shared papers)K. Höffken (1 shared paper)Jens Witte (1 shared paper)R. Pichlmayr (1 shared paper)Wolff Schmiegel (1 shared paper)I. Funke (1 shared paper)
- Journals
- Recent results in cancer research (2 papers)Journal of Clinical Oncology (1 paper)Advances in Therapy (1 paper)PubMed (2 papers)Clinical Immunotherapeutics (1 paper)
In The Last Decade
E Holz
7 papers receiving 459 citations
Peers
Comparison fields: 5 of 48
- Oncology 284
- Immunology 184
- Radiology, Nuclear Medicine and Imaging 194
- Biotechnology 39
- Pathology and Forensic Medicine 61
Countries citing papers authored by E Holz
This map shows the geographic impact of E Holz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Holz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Holz more than expected).
Fields of papers citing papers by E Holz
This network shows the impact of papers produced by E Holz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Holz. The network helps show where E Holz may publish in the future.
Co-authors
The 17 scholars most cited alongside E Holz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 407 | |
| 2 | The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A. | 2000 | 41 |
| 3 | 1996 | 9 | |
| 4 | 1996 | 8 | |
| 5 | 1998 | 4 | |
| 6 | 1996 | 3 | |
| 7 | Experimental allergic myocarditis. | 2008 | 3 |
| 8 | 2025 | 0 |
About E Holz
E Holz is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Molecular Biology, having authored 8 papers that have together received 475 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Immunotherapy and Immune Responses (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer Genomics and Diagnostics (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Oncology (284 citations), Immunology (184 citations), Radiology, Nuclear Medicine and Imaging (194 citations), Biotechnology (39 citations) and Pathology and Forensic Medicine (61 citations). E Holz has collaborated with scholars based in Germany, Poland and India. Frequent co-authors include Rudolf Gruber, G. Riethmüller, R. Raab, K. Höffken, Jens Witte, R. Pichlmayr, Wolff Schmiegel, I. Funke, H. Pichlmaier and Günter Schlimok. Their work appears in journals such as Recent results in cancer research, Journal of Clinical Oncology, Advances in Therapy, PubMed and Clinical Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.